Log in or Sign up for Free to view tailored content for your specialty!
Chronic Kidney Disease News
‘No additional benefit’ with RenalGuard for contrast-induced nephropathy after PCI
Compared with conventional IV hydration, furosemide-induced high urine output with matched hydration did not reduce risk for contrast-induced nephropathy in adults with chronic kidney disease undergoing complex CV interventions, data show.
Belimumab becomes first FDA-approved drug for pediatric lupus nephritis
The FDA has approved GlaxoSmithKline’s belimumab for the treatment of children with active lupus nephritis who are also receiving standard therapy, according to a company press release.
Log in or Sign up for Free to view tailored content for your specialty!
Patients who receive CKD education are likely to choose home dialysis at initiation
Compared with patients who did not receive chronic kidney disease education, those who did were more likely to choose home dialysis and a permanent vascular access at initiation.
Study: PCPs do not often use clinical decision support when diagnosing patients with CKD
Primary care physicians did not use clinical decision support often when diagnosing patients with chronic kidney disease, according to data published in Kidney Medicine.
Use of an arteriovenous graft in dialysis increases risk of venous thromboembolism
Compared with the use of an arteriovenous fistula, the use of an arteriovenous graft in dialysis is associated with an increased risk of venous thromboembolism, according to data published in Kidney Medicine.
Nephrologists can play a key role in the diagnosis and treatment of gout in patients with CKD
When an individual has an excess of uric acid in the blood, it can crystallize in the joints and cause gout, the most common form of inflammatory arthritis in the United States.
Rosuvastatin shows higher risks of hematuria, proteinuria, kidney failure vs atorvastatin
Compared with atorvastatin, rosuvastatin is associated with increased risks of hematuria, proteinuria and kidney failure with replacement therapy, according to a study.
European Commission grants marketing authorization for Kinpeygo
Calliditas Therapeutics AB announced the European Commission gave conditional marketing authorization for Kinpeygo.
Exposure to hurricanes significantly increases risk of death among patients on dialysis
Patients on dialysis are at a significantly heightened risk of death for 30 days after being exposed to a hurricane, according to data published in the Journal of the American Society of Nephrology.
Deteriorating renal function strong predictor of mortality after PCI
Among adults undergoing PCI, even mild to moderate chronic kidney disease is associated with decreased survival at 1 year in a dose-dependent manner, researchers reported.
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read